Oak Ridge National Laboratory

Powerful polymers: ORNL study provides new insights into N95’s COVID-19 filter efficiency

Newswise — When COVID-19 was declared a pandemic in March 2020, Oak Ridge National Laboratory’s Parans Paranthaman suddenly found himself working from home like millions of others.

A Corporate Fellow in the lab’s Chemical Sciences Division, he quickly realized his background in solid state chemistry and materials could benefit the healthcare community in need of equipment capable of filtering out COVID-19’s nanometer-size particles.

“Merlin Theodore, who leads research efforts at the Carbon Fiber Technology Facility, called me and said, ‘I need to understand which material will perform best on our production line to make N95 mask filter media, and I need to know this yesterday,’” Paranthaman recalled. “And she asked if we could use neutrons and nanoscience facilities to prove it.”

Theodore is part of a team led by ORNL Corporate Fellow Lonnie Love, who was coordinating a COVID-19 manufacturing research response as part of the Department of Energy’s National Virtual Biotechnology Laboratory. The team also consulted Peter Tsai, a retired University of Tennessee professor who invented the electrostatic charging process for creating N95 filter media, to learn how to incorporate the capability at the CFTF.

“We had never attempted something like this before in this type of timeframe,” Paranthaman said. “We were ramping up research that should have taken a year or more into a period of a few weeks with industry use by summer.”

“But there’s no challenge I haven’t met yet. The purpose of my research is to find solutions.”

Polypropylene focus

Paranthaman’s research results on the N95 filter media, recently published in ACS Applied Polymer Materials, outline the science behind what led to ORNL’s successful production of material on the CFTF’s precursor production line. The technology was later transitioned under user agreements to two industry partners — Cummins and DemeTECH — for commercial use, leading to the supply of millions of masks throughout the U.S., as well as adding thousands of jobs.

As one of the first studies on polypropylene, also known as PP, in regard to COVID-19, Paranthaman’s paper serves as a guide to understanding how a novel virus responds to polymer-based materials. PP has long been the industry standard material for filtration but understanding which commercial compounds or precursors of the material are best suited for mass production usually requires time-consuming trial and error.

“We had a unique situation with COVID-19. First, it’s a novel virus with not much known about it. Second, it’s small, ranging from 60 to 140 nanometers, which means the particles are capable of penetrating the tiniest of openings. And third, we had no time for mistakes,” Paranthaman explained. “We had to have a material that could filter out more than 95 percent of these submicron particles. It had to be virtually impermeable, but at the same time, it has to be breathable.”

The N95 mask is made of two-ply PP, a nonwoven material permanently electrostatically charged with millions of microfibers layered on top of each other to form a sheet. Theodore’s team at the CFTF used melt-blowing, which makes microfibers into a fabric by extruding a polymer resin through a die at a high air velocity, to produce three samples of commercial-grade PP for Paranthaman to evaluate.

“We used several characterization methods at ORNL to better understand the filter efficiency of PP and called upon the strengths of user facilities like the Center for Nanophase Materials Sciences and the Spallation Neutron Source,” Paranthaman said.

Characterization methods included differential scanning calorimetry to measure the amount of energy transferred between the melt-blown fibers; X-ray diffraction to understand the crystal orientation or texture of the fibers; and neutron scattering to study the molecular vibration. Scanning electron microscopy was used to understand the arrangement of the melt-blown fibers and their microstructure and to characterize their diameters.

“It’s important to understand how much of the particles the filter stops,” Paranthaman said.

The team used sodium chloride aerosol particles mimicking the size of COVID-19 to penetrate the filter, then measured the particles as they encountered the PP. Two layers of the melt-blown fiber were stacked together for testing at an airflow rate of 50 liters per minute.

Crystal clear results

Paranthaman’s research revealed that while the feedstock materials were almost identical in composition, they performed very differently when charged. The most notable difference was in crystallization, or how the material solidifies atoms and molecules into a structured form.

“We compared charged and noncharged PP material with an additive and without,” Paranthaman explained. “Crystallization had a clear impact on the material’s ability to filter in each example; a larger number of crystallites form a stronger electric charge, leading to more effective filtration.”

Research results further determined that material that has higher crystallization onset temperatures, slower crystallization and a larger number of smaller, microscopic crystallites is more effective at filtration. Paranthaman’s study of the PP samples showed which material was likely to meet the filtration target in fabric weight, efficiency, resistance, fiber diameter size and percent of electrostatic charging.

By the end of April, the CFTF was producing material that filtered 99% of the virus. By May, the technology was transferred to industry.

The research team won ORNL’s Director’s Award for Mission Support for the rapid development of the N95 filter media and technology transfer. But, Paranthaman said, the scientific work on N95 filter media is just beginning.

“This paper provided a three-dimensional look at the materials so we could see all the changes in charged fiber versus noncharged,” Paranthaman said. “We knew the charging reduces the fiber diameter, for example, but it also changes the porosity, and that’s critical to the material’s performance. Our follow-up paper will clearly outline the differences between charged and noncharged and give even greater insight into N95 filter media.”

The title of the ACS Applied Polymer Materials article is “Polymers, Additives, and Processing Effects on N95 Filter Performance.” Besides Paranthaman and Theodore, researchers on the article were Gregory Larsen, Yongqiang Cheng, Luke Daemen, Tej Lamichhane, Dale Hensley, Kunlun Hong, Harry Meyer, Emma Betters, Kim Sitzlar, Jesse Heineman, Justin West, Peter Lloyd, Vlastimil Kunc, and Lonnie Love.

ORNL’s research was conducted in coordination with the U.S. Department of Health and Human Services and supported by the DOE Office of Science through the National Virtual Biotechnology Laboratory, a consortium of DOE national laboratories focused on response to COVID-19, with funding provided by the Coronavirus CARES Act. CFTF research is also funded by the DOE’s Office Energy Efficiency and Renewable Energy’s Advanced Manufacturing Office. The Center for Nanophase Materials Sciences and Spallation Neutron Source are DOE Office of Science user facilities.

Learn more about ORNL research in the fight against COVID-19.

UT-Battelle manages Oak Ridge National Laboratory for DOE’s Office of Science, the single largest supporter of basic research in the physical sciences in the United States. DOE’s Office of Science is working to address some of the most pressing challenges of our time. For more information, visit https://energy.gov/science.










Filters close

Showing results

110 of 5849
13-Jun-2021 12:05 PM EDT
COVID-19 Pandemic Drinking: Increases Among Women, Black Adults, and People with Children
Research Society on Alcoholism

Risky drinking has been a public health concern in the U.S. for decades, but the significant increase in retail alcohol sales following COVID-19 pandemic stay-at-home orders in particular raised red flags for alcohol researchers. New research has assessed changes in alcohol drinking patterns from before to after the enactment of stay-at-home orders. These results and others will be shared at the 44th annual scientific meeting of the Research Society on Alcoholism (RSA), which will be held virtually this year from the 19th - 23rd of June 2021 due to the COVID-19 pandemic.

13-Jun-2021 1:05 PM EDT
The Impact of the COVID-19 Pandemic on Alcohol Consumption Is Far From ‘One Size Fits All’
Research Society on Alcoholism

An ongoing analysis of the effects of the COVID-19 pandemic on alcohol and related outcomes shows that COVID-related stressors experienced by study participants – including work-, financial-, and family-related stressors – are having a varied impact on individuals with and without alcohol use disorders (AUDs). These results will be shared at the 44th annual scientific meeting of the Research Society on Alcoholism (RSA), which will be held virtually this year from the 19th - 23rd of June 2021 due to the COVID-19 pandemic.

Newswise:Video Embedded newswise-expert-panels-on-covid-19-pandemic-notable-excerpts-quotes-and-videos-available
Released: 18-Jun-2021 2:10 PM EDT
Newswise Expert Panels on COVID-19 Pandemic: Notable excerpts, quotes and videos available

Newswise is hosting a series of Expert Panels discussion on unique aspects of the COVID-19 pandemic. This tip sheet includes some notable quotes from the panelists.

access_time Embargo lifts in 2 days
Embargo will expire: 23-Jun-2021 8:00 AM EDT Released to reporters: 18-Jun-2021 11:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 23-Jun-2021 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise:Video Embedded virtual-event-for-june-17-11am-edt-covid-19-vaccines-and-male-fertility
Released: 18-Jun-2021 8:55 AM EDT
VIDEO AND TRANSCRIPT AVAILABLE: Vaccines and Male Fertility Event for June 17, 2021

This upcoming JAMA-published study examined whether the COVID-19 vaccine impacts male fertility.

access_time Embargo lifts in 2 days
Embargo will expire: 22-Jun-2021 11:00 AM EDT Released to reporters: 18-Jun-2021 8:30 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 22-Jun-2021 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 18-Jun-2021 7:05 AM EDT
Teamwork saves lives: COVID-19 hospital network shares key findings to improve care
Michigan Medicine - University of Michigan

Data sharing among 40 Michigan hospitals about the care and outcomes for thousands of inpatients with COVID-19 has led to reduced variation and findings that could inform care anywhere, including approaches for preventing blood clots and reducing overuse of antibiotics, as well as a risk prediction tool.

Released: 18-Jun-2021 7:05 AM EDT
One-third of older Americans delayed health care over COVID concerns
Michigan Medicine - University of Michigan

Nearly one in three Americans between the ages of 50 and 80 put off an in-person appointment for medical care in 2020 because they were worried about exposure to the novel coronavirus, new national poll data show.

Released: 17-Jun-2021 4:15 PM EDT
UNC Researchers Lead Study of Diabetes Treatment of COVID-19 Patients
University of North Carolina School of Medicine

Diabetes is one of the comorbidities most strongly associated with severe COVID-19 in the US, and data from early in the pandemic suggested individuals with type 2 diabetes faced twice the risk of death from COVID-19 and a greater risk of requiring hospitalization and intensive care. A new study shows best treatment options.

Released: 17-Jun-2021 4:10 PM EDT
Vaccination, Previous Infection, Protect Against COVID-19 gamma/P.1 Variant in Animal Model
University of Wisconsin-Madison

In a new study using variant virus recovered from one of the original travelers, researchers in the U.S. and Japan have found that vaccination with an mRNA vaccine induces antibody responses that would protect humans from infection with the gamma/P.1 variant.

Showing results

110 of 5849